journal article·2012-01Open access

Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration

Juthamas Ratanavaraporn, Hiroyuki Furuya, Yasuhiko Tabata

Biomaterials· Volume 33· Issue 1

Abstract

The objective of this study is to investigate the effect of local inflammation suppression on the bone regeneration. Gelatin hydrogels incorporating mixed immunosuppressive triptolide-micelles and bone morphogenic protein-2 (BMP-2) were prepared. The controlled release of both the triptolide and BMP-2 from the hydrogels was observed under in vitro and in vivo conditions. When either J774.1 macrophage-like or MC3T3-E1 osteoblastic cells were cultured in the hydrogels incorporating mixed 2.5, 5 or 10 mg of triptolide-micelles and BMP-2, the expression level of pro- and anti-inflammatory cytokines including interleukin (IL)-6 and IL-10 was down-regulated, but the alkaline phosphatase (ALP) activity was promoted compared with those of hydrogels incorporating BMP-2 without triptolide-micelles. When implanted into a critical-sized bone defect of rats, the hydrogels incorporating mixed 2.5 or 5 mg of triptolide-micelles and BMP-2 showed significantly lower number of neutrophils, lymphocytes, macrophages or dendritic and mast cells infiltrated into the defect, and lower expression level of IL-6, TNF-α, and IL-10 than those incorporating BMP-2 without triptolide-micelles. The reduced local inflammation responses at the defects implanted with the hydrogels incorporating mixed 2.5 or 5 mg of triptolide-micelles and BMP-2 subsequently enhanced the bone regeneration thereat. It is concluded that the proper local modulation of inflammation responses is a promising way to achieve the enhanced bone regeneration.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Natural Compounds in Disease Treatment · Bone Metabolism and Diseases · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model10.1002/jor.20119 ↗
2. Circulating skeletal stem cells10.1083/jcb.153.5.1133 ↗
3. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair10.1016/j.bone.2005.09.015 ↗
4. Inflammation-regeneration interplay in the dentine–pulp complex10.1016/j.jdent.2010.05.016 ↗
5. Influence of anti-inflammatory and vasoactive drugs on microcirculation and angiogenesis after burn in mice10.1016/j.burns.2011.01.004 ↗
6. Topical application of dressing with amino acids improves cutaneous wound healing in aged rats10.1016/j.acthis.2009.05.003 ↗
7. Modulation of the inflammatory response for enhanced bone tissue regeneration10.1089/ten.teb.2008.0038 ↗
8. Impaired fracture healing in the absence of TNF-a signaling: the role of TNF-a in endochondral cartilage resorption10.1359/jbmr.2003.18.9.1584 ↗
9. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation10.1016/j.joca.2008.11.011 ↗
10. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds10.1016/j.biomaterials.2010.06.037 ↗
11. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function10.1016/j.biomaterials.2010.09.008 ↗
12. A non-steroidal anti-inflammatory drug (ketoprofen) does not delay b-TCP bone graft healing10.1016/j.actbio.2010.01.042 ↗
13. In vitro & in vivo assessment of a herbal formula used topically for bone fracture treatment10.1016/j.jep.2010.06.039 ↗
14. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-KappaB transcriptional activation10.1074/jbc.274.19.13443 ↗
15. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T cell proliferation and production of cytokines and chemokines10.1081/IPH-51294 ↗
16. Triptolide induces apoptotic death of T lymphocyte10.1016/S0162-3109(98)00036-8 ↗
17. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation10.1016/j.bbrc.2006.05.024 ↗
18. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine10.1097/00007890-200008150-00010 ↗
19. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract10.1097/00007890-200208270-00004 ↗
20. Screening of active anti-inflammatory, immunosuppressive and antifertility components of Tripterygium wilfordii: III. A comparison of the anti-inflammatory and immunosuppressive activities of 7 diterpene lactone epoxide compounds in vivo
21. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: triptolide and tripdiolide10.1016/0192-0561(95)00022-T ↗
22. The suppressive effect of triptolide on chronic colitis and TNF-α/TNFR2 signal pathway in interleukin-10 deficient mice10.1016/j.clim.2008.07.018 ↗
23. Triptolide affects the differentiation, maturation and function of human dendritic cells10.1016/j.intimp.2005.03.020 ↗
24. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways10.1016/j.molimm.2006.12.003 ↗
25. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein10.1016/S0142-9612(03)00337-5 ↗
26. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue10.1089/ten.tea.2009.0322 ↗
27. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration10.1016/j.biomaterials.2010.12.052 ↗
28. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels10.1016/0168-3659(94)00035-2 ↗
29. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel10.1016/S0168-3659(99)00129-7 ↗
30. A gene transfection for rat mesenchymal stromal cells in biodegradable gelatin scaffolds containing cationized polysaccharides10.1016/j.biomaterials.2010.09.056 ↗
31. Controlled delivery of T-box 21 siRNA ameliorates autoimmune alopecia (alopecia areata) in C3H/HeJ mouse model10.2353/ajpath.2008.061249 ↗
32. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel10.1016/j.jconrel.2004.11.014 ↗
33. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration10.1016/j.jconrel.2009.12.027 ↗
34. In vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods10.1163/1568562053783731 ↗
35. Controlled release of stromal cell-derived factor-1 from gelatin hydrogels enhances angiogenesis10.1163/156856209X410193 ↗
36. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and β-tricalcium phosphate10.1016/j.biomaterials.2004.09.046 ↗
37. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model10.1016/j.bone.2007.12.216 ↗
38. The critical size defect as an experimental model to test bone repair materials10.1097/00001665-199001000-00011 ↗
39. Age-associated increase in interleukin 6 in MRL/lpr mice10.1093/intimm/3.3.273 ↗
40. A study of microemulsion systems for transdermal delivery of triptolide10.1016/j.jconrel.2004.06.001 ↗
41. Anti-inflammatory effects of triptolide loaded poly(d, l-lactic acid) nanoparticles on adjuvant-induced arthritis in rats10.1016/j.jep.2004.10.031 ↗
42. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice10.1016/j.bcp.2006.08.027 ↗
43. Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle10.1016/j.ijpharm.2007.06.025 ↗
44. Dual growth factor delivery from degradable oligo (poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering10.1016/j.jconrel.2004.07.004 ↗
45. Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammation10.1152/ajplung.00014.2010 ↗
46. Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression10.1016/0192-0561(94)90044-2 ↗
47. Activity of triptolide against human mast cells harboring the kinase domain mutant KIT10.1111/j.1349-7006.2009.01159.x ↗
48. In vitro study of regulation of IL-6 production in bronchiectasis10.1016/j.rmed.2003.10.012 ↗
49. Biological properties of interleukin 1010.1007/BF00918147 ↗
50. Gene expression profiles characterize inflammation stages in the acute lung injury in mice10.1371/journal.pone.0011485 ↗
51. Immunological tolerance in a mouse model of immune-mediated liver injury induced by 16,16 dimethyl PGE2 and PGE2-containing nanoscale hydrogels10.1016/j.biomaterials.2011.03.028 ↗
52. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells10.1016/j.leukres.2004.05.014 ↗
53. Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes10.1016/j.neures.2006.02.013 ↗
54. NF-κB: linking inflammation and immunity to cancer development and progression
55. Expression of NF-κB in schwann cells and its effect on motor neuron apoptosis in spinal cord following sciatic nerves injury in rats10.1016/S1000-1948(07)60020-3 ↗
56. Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation10.1016/j.expneurol.2010.04.020 ↗
57. In vivo evaluation of the safety of triptolide-loaded hydrogel-thickened microemulsion10.1016/j.fct.2008.09.065 ↗
58. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP210.1016/j.matbio.2005.03.007 ↗
59. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat10.1007/s004180000150 ↗
60. Inhibition by dexamethasone of interleukin-ll3 and interleukin-6 expression in alveolar macrophages from cows10.1016/0034-5288(95)90028-4 ↗
61. Dose effect of tumor necrosis factor-α on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds10.1016/j.biomaterials.2009.11.058 ↗
62. Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1,25-Dihydroxyvitamin D3 works as anti-inflammatory10.1016/j.diabres.2006.10.007 ↗
63. Anti-inflammatory effect of 1α,25-dihydroxyvitamin D3 in human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease10.1016/j.jsbmb.2008.12.004 ↗